{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2025:OR3Z6FG3P5IWUP252ZCKB7BXYS","short_pith_number":"pith:OR3Z6FG3","canonical_record":{"source":{"id":"2505.03633","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.ME","submitted_at":"2025-05-06T15:33:45Z","cross_cats_sorted":["stat.AP"],"title_canon_sha256":"8e7406e062abe5c0d0920db4f2a2e683e72f10885f005c8cbf0d7846bed3ae3d","abstract_canon_sha256":"42087b1f5a312c0c05599b0b77108908f248e986114816fbeadaa0104c1b2765"},"schema_version":"1.0"},"canonical_sha256":"74779f14db7f516a3f5dd644a0fc37c499da8c149c12f53688c0db02b4c9195f","source":{"kind":"arxiv","id":"2505.03633","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2505.03633","created_at":"2026-07-05T10:59:19Z"},{"alias_kind":"arxiv_version","alias_value":"2505.03633v1","created_at":"2026-07-05T10:59:19Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2505.03633","created_at":"2026-07-05T10:59:19Z"},{"alias_kind":"pith_short_12","alias_value":"OR3Z6FG3P5IW","created_at":"2026-07-05T10:59:19Z"},{"alias_kind":"pith_short_16","alias_value":"OR3Z6FG3P5IWUP25","created_at":"2026-07-05T10:59:19Z"},{"alias_kind":"pith_short_8","alias_value":"OR3Z6FG3","created_at":"2026-07-05T10:59:19Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2025:OR3Z6FG3P5IWUP252ZCKB7BXYS","target":"record","payload":{"canonical_record":{"source":{"id":"2505.03633","kind":"arxiv","version":1},"metadata":{"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.ME","submitted_at":"2025-05-06T15:33:45Z","cross_cats_sorted":["stat.AP"],"title_canon_sha256":"8e7406e062abe5c0d0920db4f2a2e683e72f10885f005c8cbf0d7846bed3ae3d","abstract_canon_sha256":"42087b1f5a312c0c05599b0b77108908f248e986114816fbeadaa0104c1b2765"},"schema_version":"1.0"},"canonical_sha256":"74779f14db7f516a3f5dd644a0fc37c499da8c149c12f53688c0db02b4c9195f","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-07-05T10:59:19.673188Z","signature_b64":"l3es/YtoRIURhq58VUU/3gd1Z1VzOtPnE8jStghjDIDLW5VJs1Ddrp2sOMQZd/5V3DmSxAFkZcfpfJW2NuPwAw==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"74779f14db7f516a3f5dd644a0fc37c499da8c149c12f53688c0db02b4c9195f","last_reissued_at":"2026-07-05T10:59:19.672717Z","signature_status":"signed_v1","first_computed_at":"2026-07-05T10:59:19.672717Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"2505.03633","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-07-05T10:59:19Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"TGbAWrxLrFYrGvg926dQi7RruE2hUr12t0fSJTyfqz4rk3c9StFXZdyJmjZ2n6Km53rmzy6PRhEWdFnm4gJiBQ==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-22T13:22:21.004955Z"},"content_sha256":"b4dff55df9189deb63fcfd6dadbad4b56c2df9ec4480646a4bf066e2357e4df6","schema_version":"1.0","event_id":"sha256:b4dff55df9189deb63fcfd6dadbad4b56c2df9ec4480646a4bf066e2357e4df6"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2025:OR3Z6FG3P5IWUP252ZCKB7BXYS","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"CUI-MET: Clinical Utility Index Dose Optimization Approach for Multiple-Dose, Multiple-Outcome Randomized Trial Designs","license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","headline":"","cross_cats":["stat.AP"],"primary_cat":"stat.ME","authors_text":"Fanni Zhang, Gina D'Angelo, Kristine Broglio, Michael Sweeting","submitted_at":"2025-05-06T15:33:45Z","abstract_excerpt":"Dose optimization in oncology clinical trials has shifted from seeking the maximum tolerated dose to identifying the Optimal Biological Dose (OBD) that balances therapeutic benefits and risks across multiple clinical attributes. Existing advanced dose-finding methods can integrate multiple endpoints and compare dose levels but are often complex or computationally intensive, limiting their use in early-phase trials. To address these challenges, we propose the Clinical Utility Index Dose Optimization Approach for Multiple-dose Multiple-Outcome Randomized Trial Designs (CUI-MET). This framework i"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2505.03633","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"integrity":{"clean":true,"summary":{"advisory":0,"critical":0,"by_detector":{},"informational":0},"endpoint":"/pith/2505.03633/integrity.json","findings":[],"available":true,"detectors_run":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938"},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-07-05T10:59:19Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"OJ0Yj9lSPBHEbqDsQvylkgHtYU73YXNxiy2KpJS1UdWxPLdBAuP4LjC6KKieq54TqKgaJjhvqvkSl5sbYC89DA==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-08-22T13:22:21.005467Z"},"content_sha256":"afddd31675fa881f183397cc05e703f57ae2e5cf5c6f3f90cd0cf0a216868c54","schema_version":"1.0","event_id":"sha256:afddd31675fa881f183397cc05e703f57ae2e5cf5c6f3f90cd0cf0a216868c54"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/OR3Z6FG3P5IWUP252ZCKB7BXYS/bundle.json","state_url":"https://pith.science/pith/OR3Z6FG3P5IWUP252ZCKB7BXYS/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/OR3Z6FG3P5IWUP252ZCKB7BXYS/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-08-22T13:22:21Z","links":{"resolver":"https://pith.science/pith/OR3Z6FG3P5IWUP252ZCKB7BXYS","bundle":"https://pith.science/pith/OR3Z6FG3P5IWUP252ZCKB7BXYS/bundle.json","state":"https://pith.science/pith/OR3Z6FG3P5IWUP252ZCKB7BXYS/state.json","well_known_bundle":"https://pith.science/.well-known/pith/OR3Z6FG3P5IWUP252ZCKB7BXYS/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2025:OR3Z6FG3P5IWUP252ZCKB7BXYS","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"42087b1f5a312c0c05599b0b77108908f248e986114816fbeadaa0104c1b2765","cross_cats_sorted":["stat.AP"],"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.ME","submitted_at":"2025-05-06T15:33:45Z","title_canon_sha256":"8e7406e062abe5c0d0920db4f2a2e683e72f10885f005c8cbf0d7846bed3ae3d"},"schema_version":"1.0","source":{"id":"2505.03633","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"2505.03633","created_at":"2026-07-05T10:59:19Z"},{"alias_kind":"arxiv_version","alias_value":"2505.03633v1","created_at":"2026-07-05T10:59:19Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.2505.03633","created_at":"2026-07-05T10:59:19Z"},{"alias_kind":"pith_short_12","alias_value":"OR3Z6FG3P5IW","created_at":"2026-07-05T10:59:19Z"},{"alias_kind":"pith_short_16","alias_value":"OR3Z6FG3P5IWUP25","created_at":"2026-07-05T10:59:19Z"},{"alias_kind":"pith_short_8","alias_value":"OR3Z6FG3","created_at":"2026-07-05T10:59:19Z"}],"graph_snapshots":[{"event_id":"sha256:afddd31675fa881f183397cc05e703f57ae2e5cf5c6f3f90cd0cf0a216868c54","target":"graph","created_at":"2026-07-05T10:59:19Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"integrity":{"available":true,"clean":true,"detectors_run":[],"endpoint":"/pith/2505.03633/integrity.json","findings":[],"snapshot_sha256":"c28c3603d3b5d939e8dc4c7e95fa8dfce3d595e45f758748cecf8e644a296938","summary":{"advisory":0,"by_detector":{},"critical":0,"informational":0}},"paper":{"abstract_excerpt":"Dose optimization in oncology clinical trials has shifted from seeking the maximum tolerated dose to identifying the Optimal Biological Dose (OBD) that balances therapeutic benefits and risks across multiple clinical attributes. Existing advanced dose-finding methods can integrate multiple endpoints and compare dose levels but are often complex or computationally intensive, limiting their use in early-phase trials. To address these challenges, we propose the Clinical Utility Index Dose Optimization Approach for Multiple-dose Multiple-Outcome Randomized Trial Designs (CUI-MET). This framework i","authors_text":"Fanni Zhang, Gina D'Angelo, Kristine Broglio, Michael Sweeting","cross_cats":["stat.AP"],"headline":"","license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.ME","submitted_at":"2025-05-06T15:33:45Z","title":"CUI-MET: Clinical Utility Index Dose Optimization Approach for Multiple-Dose, Multiple-Outcome Randomized Trial Designs"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"2505.03633","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:b4dff55df9189deb63fcfd6dadbad4b56c2df9ec4480646a4bf066e2357e4df6","target":"record","created_at":"2026-07-05T10:59:19Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"42087b1f5a312c0c05599b0b77108908f248e986114816fbeadaa0104c1b2765","cross_cats_sorted":["stat.AP"],"license":"http://creativecommons.org/licenses/by-nc-nd/4.0/","primary_cat":"stat.ME","submitted_at":"2025-05-06T15:33:45Z","title_canon_sha256":"8e7406e062abe5c0d0920db4f2a2e683e72f10885f005c8cbf0d7846bed3ae3d"},"schema_version":"1.0","source":{"id":"2505.03633","kind":"arxiv","version":1}},"canonical_sha256":"74779f14db7f516a3f5dd644a0fc37c499da8c149c12f53688c0db02b4c9195f","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"74779f14db7f516a3f5dd644a0fc37c499da8c149c12f53688c0db02b4c9195f","first_computed_at":"2026-07-05T10:59:19.672717Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-07-05T10:59:19.672717Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"l3es/YtoRIURhq58VUU/3gd1Z1VzOtPnE8jStghjDIDLW5VJs1Ddrp2sOMQZd/5V3DmSxAFkZcfpfJW2NuPwAw==","signature_status":"signed_v1","signed_at":"2026-07-05T10:59:19.673188Z","signed_message":"canonical_sha256_bytes"},"source_id":"2505.03633","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:b4dff55df9189deb63fcfd6dadbad4b56c2df9ec4480646a4bf066e2357e4df6","sha256:afddd31675fa881f183397cc05e703f57ae2e5cf5c6f3f90cd0cf0a216868c54"],"state_sha256":"156a80055521e8ca9f5e479e97b74ff9ab72aa6ac44bbf9b88387141a52689b4"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"gnCoJMa+OiTset0wEkO5sC93QdsoZ6GbL1HldNZcmJW4MslAnXKOTbz86fiiGcIyEiSNK+I1IibgmwAPm3oLAg==","signed_message":"bundle_sha256_bytes","signed_at":"2026-08-22T13:22:21.009610Z","bundle_sha256":"5bb657b49698861f197145fb3a8c3e97f3f3d864d225501b554ec8218b552167"}}